The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs
From Nature, 12 February 2026: What do tennis star Serena Williams, television personality Oprah Winfrey and actors Kathy Bates and Whoopi Goldberg have in common? They are some of the many celebrities who have spoken publicly about using GLP-1 receptor agonists to lose weight. Glucagon-like peptide-1 (GLP-1) receptor agonists — which bind to GLP-1 receptors … Continue reading The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs
Bianca Nogrady 